Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore N J Patel and N L Upadhyaya Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91.The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets capsules etc besides diversifying into bulk drugs and setting up an injectables unit. The project cost of Rs 14.21 cr was financed through loans and equity. The project was delayed by about nine months and was completed in 1995.The company undertakes job work/loan license work of reputed pharmaceuticals majors and expects to continue with the present arrangement besides expecting big boost in exports in the coming years with the PHC groups focus and marketing strengths worldwide. |
Norris Medicines Ltd.
BSE: 524414 | Sector: Others |
NSE: N.A. | ISIN Code: INE744C01029 |
BSE 00:00 | 12 Aug | 10.48 |
0.09 (0.87%) |
OPEN
10.49 |
HIGH
10.49 |
LOW
9.90 |
NSE 05:30 | 01 Jan | Norris Medicines Ltd |
OPEN | 10.49 |
PREVIOUS CLOSE | 10.39 |
VOLUME | 86 |
52-Week high | 36.75 |
52-Week low | 7.85 |
P/E | |
Mkt Cap.(Rs cr) | 10 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Norris Medicines Ltd. (NORRISMEDICINES) - Company History
Quick Links for Norris Medicines:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices